A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Sykehuset Innlandet HF
Calibr, a division of Scripps Research
Canadian Cancer Trials Group
University of Michigan
National Institutes of Health Clinical Center (CC)
University of Massachusetts, Amherst
Aptarion Biotech AG
Pharmacyclics LLC.
SWOG Cancer Research Network
University of Chicago
Allogene Therapeutics
BeOne Medicines
AstraZeneca
BeOne Medicines
Alzheimer's Prevention and Reversal Project, Inc.
University Hospital, Rouen
Espad Pharmed
Universitas Padjadjaran
Eli Lilly and Company
Celgene
University of Baghdad
Hope Biosciences Research Foundation
Novartis
Riphah International University
Flint Rehabilitation Devices, LLC
Gilead Sciences
Fayoum University
Acerta Pharma BV
Novartis
H. Lee Moffitt Cancer Center and Research Institute
Hennepin Healthcare Research Institute
Massachusetts General Hospital
DongE E Jiao Coporation Limited
National Cancer Institute (NCI)
BeOne Medicines
Beni-Suef University
University of Pittsburgh
University of Arizona
Medical University of South Carolina
Ipsen
Thomas Jefferson University
Dana-Farber Cancer Institute
Regeneron Pharmaceuticals
Novartis
Bristol-Myers Squibb
The Lymphoma Academic Research Organisation
AstraZeneca
Boryung Pharmaceutical Co., Ltd
Kocaeli City Hospital